CVS Health stock at USD 89.13 on September 25, 2026
Published on 09/26/2026 at 17:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CVS Health stock last traded at USD 89.13 on September 25, 2026, with a daily gain of 4.80 percent. The quote refers to CVS Health Corp.’s New York Stock Exchange listing. Separately, the company’s latest reported operating update came from its second-quarter earnings call on August 5, 2026, when management outlined higher full-year expectations and developments across its healthcare businesses.
Second-quarter performance
CVS Health reported second-quarter revenue of USD 106.1 billion and adjusted earnings per share of USD 2.58 on the August 5 call. Management said adjusted operating income was approximately USD 5.2 billion, while year-to-date operating cash flow reached approximately USD 10.6 billion. The figures cover the quarter ended June 30, 2026, and include non-GAAP measures where identified by the company. CVS Health’s earnings-call transcript records the company’s prepared remarks and financial outlook.
Within Health Care Benefits, CVS Health said quarterly revenue exceeded USD 37 billion and medical membership was approximately 26 million at quarter-end. Adjusted operating income was approximately USD 2.4 billion, while the medical benefit ratio was 87.4 percent. Management attributed the segment’s performance to medical-cost management and disciplined pricing, while noting that individual-exchange business exits affected year-over-year membership.
Raised 2026 outlook
CVS Health increased its full-year 2026 adjusted EPS guidance by USD 0.60 to a range of USD 7.90 to USD 8.10. The company also raised its operating-cash-flow outlook to at least USD 11.5 billion and set a full-year revenue expectation of at least USD 414 billion. The guidance was presented as the company’s outlook for fiscal 2026, rather than as a second-quarter actual result. The transcript also details segment-level assumptions behind the updated forecast.
Management projected full-year adjusted operating income of USD 5.03 billion to USD 5.37 billion for Health Care Benefits and at least USD 6.4 billion for Pharmacy and Consumer Wellness. The enterprise adjusted operating-income outlook was set at USD 16.58 billion to USD 16.92 billion. CVS Health said the current outlook did not assume share repurchases during 2026.
Business conditions and priorities
In its September 9 appearance at the Wells Fargo healthcare conference, CVS Health described progress across Aetna, pharmacy services and Oak Street Health while acknowledging elevated medical-cost trends. The company said it was using pricing discipline, operational changes and technology investments across the businesses. Investing.com’s conference transcript report attributed those comments to CVS Health executives.
The company also discussed pressure in the 340B business and possible membership effects in Caremark. At the August earnings call, management said 340B-related pressure had been offset by broader Caremark performance in the quarter, while specialty pharmacy, pharmacy operations and healthcare delivery remained areas of focus. CVS Health additionally described ongoing work on prior authorization, artificial intelligence and digital tools for members and providers.
CVS Health’s September 9 conference comments included balance-sheet and capital-allocation discussion. Management said leverage had improved to the mid-3s from 5 times debt to EBITDA in 2024 and that the company had paid down USD 4 billion of debt in 2025. The company said future capital decisions would balance debt reduction, dividends, repurchases and bolt-on acquisitions, subject to its capital framework.
On September 25, CVS shares recorded the quoted regular-session result shown above. The stock data and the dated company disclosures describe separate facts: the price reflects the September 25 New York Stock Exchange session, while the operating information comes from company remarks dated August 5 and September 9, 2026.
CVS Health Corp. stock at a glance
- Company: CVS Health Corp.
- ISIN: US1266501006
- Ticker: CVS
- Primary exchange: New York Stock Exchange
- Core quote: USD 89.13 on September 25, 2026
- Daily change: Up 4.80 percent
